Individual Study / CKB

China Kadoorie Biobank

China Kadoorie Biobank

CKB logo
Initiatives -
Start Year
It was established with funding support to University of Oxford’s Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) from the Kadoorie Charitable Foundation (KCF) in Hong Kong. The long-term continuation of the study is supported by the Wellcome Trust, with further support in China from the Chinese Natural Science Foundation and Chinese Ministry of Science and Technology. The UK Medical Research Council (MRC), British Heart Foundation (BHF) and Cancer Research UK (CRUK) also provide core funding to CTSU for the project.
Supplementary Information
Visit CKB


Investigators Contacts
  • Dr. Prof. Liming Li
    Peking University Health Science Center
  • Dr. Prof. Chen Zhengming
    China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU)


Study design
Population cohort
Follow Up
All the participants are now being closely monitored for death and other health-related outcomes through linkage with established registries and health insurance databases in the study areas. Every few years, periodic re-surveys are also to be conducted in about 25,000 surviving participants, with a repeat interview, measurements and blood collection (as in the baseline survey) to help assess changes of risk exposures in the study population.
Supplementary Information

Marker Paper

Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652-1666. doi:10.1093/ije/dyr120

PUBMED 22158673


Sources of Recruitment
  • Individuals

Number of participants

Number of participants
Number of participants with biosamples


Availability of data and biosamples


Availability of access information

On the study website :